BHCM
COLL icon

Brevan Howard Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Brevan Howard Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Sell
13,113
-35,648
-73% -$1.22M ﹤0.01% 1478
2026
Q1 		$1.61M Buy
48,761
+37,015
+315% +$1.57M 0.01% 658
2025
Q4 		$544K Buy
+11,746
New +$491K 0.01% 1067
2025
Q1 		– Sell
-9,804
Closed -$281K – 1202
2024
Q4 		$281K Buy
+9,804
New +$324K ﹤0.01% 797

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Brevan Howard Capital Management's COLL Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Collegium Pharmaceutical (COLL) stake by 73% in Q2 2026, selling an estimated $1.22M and leaving 13,113 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #1478.

Brevan Howard Capital Management first reported a position in COLL in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.61M in Q1 2026. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Brevan Howard Capital Management held 13,113 shares of Collegium Pharmaceutical worth $475K as of Q2 2026.
  • Brevan Howard Capital Management sold 35,648 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.22M.
  • Collegium Pharmaceutical made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1478 holding.
  • Brevan Howard Capital Management first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 4 quarters since.
  • Brevan Howard Capital Management's Collegium Pharmaceutical position peaked at $1.61M in Q1 2026.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.